BioMarin Pharma (BMRN) Tops Q1 EPS by 32c, Offers Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. WDAY
2. AAPL
3. JNJ
4. META
5. NRIX
6. SUNS
7. OIG
8. SPY
9. SNDX
10. CRDO

Go back to BioMarin Pharma (BMRN) Tops Q1 EPS by 32c, Offers Guidance

BioMarin Announces First Quarter 2016 Financial Results

April 28, 2016 4:02 PM EDT

-First Quarter 2016 Total BioMarin Revenue Increases 16.7% Y/Y to $236.7 million

-Vimizim Net Product Revenue Increases 43.5% Y/Y and Contributes $72.6 million in the First Quarter 2016; Vimizim Full-year Revenue Guidance Increased to $315 to $340 million

- Kuvan Net Product Revenue Contributes $76.9 million in the First Quarter 2016; $60.0 million from North America and $16.9 million from Newly Acquired ex-North American Territories

 Financial Highlights (in millions of U.S. dollars, except per share data, unaudited)

  Three Months Ended March... More